glp 1 masld Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive GLP-1 therapies target MASLD/MASH pathophysiology

Research tells us that overweight or obese individuals might have impairments in dopaminergic pathways associated with reward sensitivity, leading to food noise: Eating decadent food prompts a dopamine surge, so you feel compelled to eat even when you arent hungry to get your fix. Satiety vs

J Clin Endocrinol Metab 90(4):19291935

I now believe I developed IIH [idiopathic intracranial hypertension] as a result of taking Ozempic

PROPKA3: consistent treatment of internal and surface residues in empirical pka predictions

Biophys Res

In the middle employer and health plan leaders tasked with developing a benefits strategy that satisfies high demand from people they serve without impacting the bottom line